Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 22, 2022, titled "Alembic Pharmaceuticals announces its first product approval from its Formulation Division IV, Jarod Facility".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 22, 2022, titled "Alembic Pharmaceuticals announces its first product approval from its Formulation Division IV, Jarod Facility".